Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1626-1633

  Moghaddam, Amin E ^a   Gartlan, Kate H ^a   Kong, Leopold ^a   Sattentau, Quentin J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 6 N CARBOXYMETHYLLYSINE; ALDEHYDE DERIVATIVE; CARBONYL DERIVATIVE; GAMMA INTERFERON; GLYCOALDEHYDE; IMMUNOGLOBULIN G1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MALONALDEHYDE; PYRIDINE; REACTIVE CARBONYL; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNIZATION; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ALDEHYDES; ANIMALS; ANTIGENS; CYTOKINES; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, SCID; OXIDATIVE STRESS; TH1 CELLS; TH2 CELLS;

EID: 80051935634     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003906     Document Type: Article

References (51)

1. Rock, K. L., E. Latz, F. Ontiveros, and H. Kono. 2010. The sterile inflammatory response. Annu. Rev. Immunol. 28: 321-342.
2. Matzinger, P. 2002. The danger model: A renewed sense of self. Science 296: 301-305. (Pubitemid 34303674)
3. Medzhitov, R., and C. A. Janeway Jr. 1997. Innate immunity: The virtues of a nonclonal system of recognition. Cell 91: 295-298. (Pubitemid 27467959)
4. Dalle-Donne, I., G. Aldini, M. Carini, R. Colombo, R. Rossi, and A. Milzani. 2006. Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 10: 389-406. (Pubitemid 44870187)
5. Negre-Salvayre, A., N. Auge, V. Ayala, H. Basaga, J. Boada, R. Brenke, S. Chapple, G. Cohen, J. Feher, T. Grune, et al. 2010. Pathological aspects of lipid peroxidation. Free Radic. Res. 44: 1125-1171.
6. O'Brien, P. J., A. G. Siraki, and N. Shangari. 2005. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 35: 609-662. (Pubitemid 41693601)
7. Hartvigsen, K., M. Y. Chou, L. F. Hansen, P. X. Shaw, S. Tsimikas, C. J. Binder, and J. L. Witztum. 2009. The role of innate immunity in atherogenesis. J. Lipid Res. 50(Suppl): S388-S393.
8. Hazen, S. L. 2008. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J. Biol. Chem. 283: 15527-15531.
9. Kurien, B. T., and R. H. Scofield. 2008. Autoimmunity and oxidatively modified autoantigens. Autoimmun. Rev. 7: 567-573.
10. Lopes-Virella, M. F., and G. Virella. 2010. Clinical significance of the humoral immune response to modified LDL. Clin. Immunol. 134: 55-65.
11. Duryee, M. J., L. W. Klassen, and G. M. Thiele. 2007. Immunological response in alcoholic liver disease. World J. Gastroenterol. 13: 4938-4946. (Pubitemid 47496825)
12. Stadtman, E. R., and R. L. Levine. 2000. Protein oxidation. Ann. N. Y. Acad. Sci. 899: 191-208. (Pubitemid 30352787)
13. Glomb, M. A., and V. M. Monnier. 1995. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 270: 10017-10026.
14. Anderson, M. M., S. L. Hazen, F. F. Hsu, and J. W. Heinecke. 1997. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,β-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99: 424-432. (Pubitemid 27414799)
15. Allison, M. E. D., and D. T. Fearon. 2000. Enhanced immunogenicity of aldehyde-bearing antigens: A possible link between innate and adaptive immunity. Eur. J. Immunol. 30: 2881-2887.
16. Moghaddam, A., W. Olszewska, B. Wang, J. S. Tregoning, R. Helson, Q. J. Sattentau, and P. J. Openshaw. 2006. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nat. Med. 12: 905-907. (Pubitemid 44175141)
17. Esterbauer, H., R. J. Schaur, and H. Zollner. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11: 81-128. (Pubitemid 121003917)
18. Negre-Salvayre, A., C. Coatrieux, C. Ingueneau, and R. Salvayre. 2008. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 153: 6-20.
19. Scofield, R. H., B. T. Kurien, S. Ganick, M. T. McClain, Q. Pye, J. A. James, R. I. Schneider, R. H. Broyles, M. Bachmann, and K. Hensley. 2005. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radic. Biol. Med. 38: 719-728. (Pubitemid 40249742)
20. Duryee, M. J., L. W. Klassen, C. S. Schaffert, D. J. Tuma, C. D. Hunter, R. P. Garvin, D. R. Anderson, and G. M. Thiele. 2010. Malondialdehyde- acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic. Biol. Med. 49: 1480-1486.
21. Bruenner, B. A., A. D. Jones, and J. B. German. 1995. Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry. Chem. Res. Toxicol. 8: 552-559.
22. Ishii, T., S. Kumazawa, T. Sakurai, T. Nakayama, and K. Uchida. 2006. Mass spectroscopic characterization of protein modification by malondialdehyde. Chem. Res. Toxicol. 19: 122-129. (Pubitemid 43185470)
23. Kikugawa, K., and Y. Ido. 1984. Studies on peroxidized lipids. 5. Formation and characterization of 1,4-dihydropyridine-3,5-dicarbaldehydes as model of fluorescent components in lipofuscin. Lipids 19: 600-608. (Pubitemid 14034535)
24. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986. (Pubitemid 30148956)
25. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92. (Pubitemid 29096240)
26. Buss, H., T. P. Chan, K. B. Sluis, N. M. Domigan, and C. C. Winterbourn. 1997. Protein carbonyl measurement by a sensitive ELISA method. Free Radic. Biol. Med. 23: 361-366. (Pubitemid 27276771)
27. Acharya, A. S., and J. M. Manning. 1983. Reaction of glycolaldehyde with proteins: Latent crosslinking potential of alpha-hydroxyaldehydes. Proc. Natl. Acad. Sci. USA 80: 3590-3594.
28. Des Rosiers, C., M. J. Rivest, M. J. Boily, M. Jetté, A. Carrobé-Cohen, and A. Kumar. 1993. Gas chromatographic-mass spectrometric assay of tissue malondialdehyde, 4-hydroxynonenal, and other aldehydes after their reduction to stable alcohols. Anal. Biochem. 208: 161-170. (Pubitemid 23087015)
29. Perlin, A. S. 2006. Glycol-cleavage oxidation. Adv. Carbohydr. Chem. Biochem. 60: 183-250. (Pubitemid 43783386)
30. Kislinger, T., C. Fu, B. Huber, W. Qu, A. Taguchi, S. Du Yan, M. Hofmann, S. F. Yan, M. Pischetsrieder, D. Stern, and A. M. Schmidt. 1999. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274: 31740-31749.
31. Ilchmann, A., S. Burgdorf, S. Scheurer, Z. Waibler, R. Nagai, A. Wellner, Y. Yamamoto, H. Yamamoto, T. Henle, C. Kurts, U. Kalinke, S. Vieths, and M. Toda. 2010. Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: Role of macrophage scavenger receptor class A type I and II. J. Allergy Clin. Immunol. 125: 175-183.
32. Nagai, R., C. M. Hayashi, L. Xia, M. Takeya, and S. Horiuchi. 2002. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J. Biol. Chem. 277: 48905-48912. (Pubitemid 35470860)
33. Anderer, F. A., and H. D. Schlumberger. 1969. Antigenic properties of proteins cross-linked by multidiazonium compounds. Immunochemistry 6: 1-10.
34. Rizzo, L. V., R. H. DeKruyff, D. T. Umetsu, and R. R. Caspi. 1995. Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo. Eur. J. Immunol. 25: 708-716.
35. Charles, P. C., K. S. Weber, B. Cipriani, and C. F. Brosnan. 1999. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: Implications for establishment of a Th1/Th2 bias. J. Neuroimmunol. 100: 64-73. (Pubitemid 30038240)
36. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26: 1553-1559. (Pubitemid 26230002)
37. Horiuchi, S., M. Murakami, K. Takata, and Y. Morino. 1986. Scavenger receptor for aldehyde-modified proteins. J. Biol. Chem. 261: 4962-4966. (Pubitemid 17204287)
38. Nagai, R., K. Matsumoto, X. Ling, H. Suzuki, T. Araki, and S. Horiuchi. 2000. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49: 1714-1723.
39. Willis, M. S., G. M. Thiele, D. J. Tuma, and L. W. Klassen. 2003. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Int. Immunopharmacol. 3: 1381-1399. (Pubitemid 37025719)
40. Thiele, G. M., D. J. Tuma, M. S. Willis, J. A. Miller, T. L. McDonald, M. F. Sorrell, and L. W. Klassen. 1998. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. Alcohol. Clin. Exp. Res. 22: 1731-1739. (Pubitemid 28536164)
41. Wuttge, D. M., M. Bruzelius, and S. Stemme. 1999. T-cell recognition of lipid peroxidation products breaks tolerance to self proteins. Immunology 98: 273-279. (Pubitemid 29487650)
42. Palinski, W., S. Ylä-Herttuala, M. E. Rosenfeld, S. W. Butler, S. A. Socher, S. Parthasarathy, L. K. Curtiss, and J. L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10: 325-335. (Pubitemid 20178661)
43. Ylä-Herttuala, S., W. Palinski, S. W. Butler, S. Picard, D. Steinberg, and J. L. Witztum. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14: 32-40.
44. Wållberg, M., J. Bergquist, A. Achour, E. Breij, and R. A. Harris. 2007. Malondialdehyde modification of myelin oligodendrocyte glycoprotein leads to increased immunogenicity and encephalitogenicity. Eur. J. Immunol. 37: 1986-1995. (Pubitemid 47065134)
45. Willis, M. S., L. W. Klassen, D. J. Tuma, M. F. Sorrell, and G. M. Thiele. 2002. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol. Clin. Exp. Res. 26: 94-106. (Pubitemid 34093516)
46. Negre-Salvayre, A., R. Salvayre, N. Augé, R. Pamplona, and M. Portero-Otín. 2009. Hyperglycemia and glycation in diabetic complications. Antioxid. Redox Signal. 11: 3071-3109.
47. Jankovic, D., S. Steinfelder, M. C. Kullberg, and A. Sher. 2006. Mechanisms underlying helminth- induced Th2 polarization: Default, negative or positive pathways? Chem. Immunol. Allergy 90: 65-81. (Pubitemid 43265668)
48. Paul, W. E., and J. Zhu. 2010. How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol. 10: 225-235.
49. Prokopowicz, Z. M., F. Arce, R. Biedroń, C. L. Chiang, M. Ciszek, D. R. Katz, M. Nowakowska, S. Zapotoczny, J. Marcinkiewicz, and B. M. Chain. 2010. Hypochlorous acid: A natural adjuvant that facilitates antigen processing, crosspriming, and the induction of adaptive immunity. J. Immunol. 184: 824-835.
50. Palinski, W., E. Miller, and J. L. Witztum. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA 92: 821-825.
51. George, J., A. Afek, B. Gilburd, H. Levkovitz, A. Shaish, I. Goldberg, Y. Kopolovic, G. Wick, Y. Shoenfeld, and D. Harats. 1998. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138: 147-152. (Pubitemid 28255163)